Revenio Group Oyj (HEL: REG1V)

Market Cap	898.94M
Revenue (ttm)	100.49M
Net Income (ttm)	19.31M
Shares Out	26.60M
EPS (ttm)	0.73
PE Ratio	46.35
Forward PE	37.27
Dividend	0.38 (1.14%)
Ex-Dividend Date	Apr 5, 2024

Volume	23,726
Open	33.50
Previous Close	33.40
Day's Range	33.50 - 33.98
52-Week Range	17.51 - 33.98
Beta	1.34
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2024

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 229
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2023, REG1V's revenue was 96.79 million, a decrease of -0.46% compared to the previous year's 97.23 million. Earnings were 19.11 million, a decrease of -12.15%.